[2010 Chinese guidelines for the management of hypertension].
Li-sheng Liu
|
10 |
2011 |
10
2011
|
[Chinese guidelines on prevention and treatment of dyslipidemia in adults].
|
9 |
2007 |
9
2007
|
[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].
10 auth.
Yudong Peng,
K. Meng,
H. Guan,
Liang Leng,
Ruirui Zhu,
Boyuan Wang,
...
M. He,
Longxian Cheng,
Kai Huang,
Qiutang Zeng
|
8 |
2020 |
8
2020
|
[Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].
Cheng Chen,
Jiangtao Yan,
Ning Zhou,
Jianping Zhao,
D. Wang
|
8 |
2020 |
8
2020
|
[Update on myocardial bridging].
M. Dong,
J. Qian
|
8 |
2006 |
8
2006
|
[Chinese guidelines for the diagnosis and treatment of heart failure 2018].
|
7 |
2018 |
7
2018
|
[2016 Chinese guideline for the management of dyslipidemia in adults].
|
7 |
2016 |
7
2016
|
[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].
9 auth.
Xing-wei He,
Jinsheng Lai,
Jia Hua Cheng,
Mengwen Wang,
Yunjian Liu,
Zhichao Xiao,
...
Chang Xu,
Shusheng Li,
H. Zeng
|
7 |
2020 |
7
2020
|
[Rethinking, comment and query of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults].
D. Hu
|
6 |
2014 |
6
2014
|
[Key points and comments on the 2016 Chinese guideline for the management of dyslipidemia in adults].
S. Zhao
|
6 |
2016 |
6
2016
|
[Chinese guidelines for lipid management (2023)].
|
6 |
2023 |
6
2023
|
[2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction].
|
6 |
2019 |
6
2019
|
[Chinese guideline on the primary prevention of cardiovascular diseases].
|
5 |
2020 |
5
2020
|
